17 Sep 2019

Malaria kills more than 400,000 people a year worldwide and causes illness in tens of millions more, with most deaths occurring among young children living in sub-Saharan Africa.

RTS,S/AS01 (RTS,S) is the first malaria vaccine shown to provide partial protection against malaria in young children. It is the first malaria vaccine to be provided to young children through national immunization programs in three sub-Saharan African countries—Ghana, Kenya, and Malawi. These countries will introduce the vaccine in selected areas as part of a large-scale pilot implementation program coordinated by the World Health Organization (WHO), in partnership with the health ministry in each country and in collaboration with international partners, including PATH and GSK, manufacturer of the vaccine.